Laura Graham, MD

Clinicians explore the limitations of cross-trial comparisons in treatment efficacy, emphasizing the need for randomized evidence over MAIC insights.

Clinicians explore the limitations of cross-trial comparisons in treatment efficacy, emphasizing the need for randomized evidence over MAIC insights.

Clinicians emphasize the importance of personalized treatment strategies in metastatic hormone-sensitive cancer, considering patient-specific factors and trial insights.

Healthcare professionals navigate complex treatment options for high-risk biochemical recurrence, emphasizing patient preferences and quality of life in decision-making.

Explore the evolving landscape of monotherapy for high-risk biochemical recurrence, focusing on patient selection and treatment outcomes.

Structured exercise plays a vital role in managing fatigue and improving overall health for patients, especially those undergoing cancer treatment.

Healthcare professionals assess and manage fatigue in prostate cancer patients by evaluating severity, identifying reversible causes, and adjusting treatments for better quality of life.

Recent ARCH trial data reveals significant survival benefits of enzalutamide combined with ADT for metastatic hormone-sensitive prostate cancer patients.

Recent ARCH trial data reveals significant survival benefits of enzalutamide combined with ADT for metastatic hormone-sensitive prostate cancer patients.

Recent ARCH trial data reveals significant survival benefits of enzalutamide combined with ADT for metastatic hormone-sensitive prostate cancer patients.

Dr. Graham discusses the impact of long-term survival data on treatment strategies for metastatic hormone-sensitive prostate cancer, emphasizing patient-specific approaches.

Explore the complexities of treatment interruption and resumption in prostate cancer therapy, including patient counseling and PSA monitoring strategies.

Dr. Graham discusses the EMBARK study's findings on treatment suspension strategies for high-risk biochemical recurrence, highlighting survival benefits and future implications.

Explore the latest advancements in prostate cancer management, focusing on survival data, treatment strategies, and patient care considerations.

Explore the latest advancements in prostate cancer management, focusing on survival data, treatment strategies, and patient care considerations.